SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is highly volatile amid escalating Middle East tensions, with initial surges driven by Strait of Hormuz disruption fears and production cuts now battling signals of de-escalation from presidential remarks and G7 discussions on strategic oil reserve releases. This has led to a polarized community debate on its immediate trajectory.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending after reporting robust Q4 earnings that significantly surpassed expectations, driven by strong sales of its rare disease drug MIPLYFFA and marking the company's achievement of profitability. This financial performance is fueling widespread community excitement, with many speculating on a potential short squeeze and re-evaluating the stock's value as a commercially successful rare disease player.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is drawing significant attention after being selected for a White House-backed eVTOL integration program to accelerate U.S. operations, alongside the launch of Uber Air in Dubai for commercial service. The community is actively debating these tangible commercialization milestones and progress towards FAA certification, even as new allegations from a competitor's lawsuit and a short report fuel further discussion.

Voyager Technologies, Inc. engages in the defense technology and space solutions. It operates through the following segments: Defense & National Security, Space Solutions, and Starlab Space Stations. The Defense & National Security segment consists of innovative mission-critical solutions to protect dynamic and contested domains. The Space Solutions segment consists of space infrastructure, advanced space technology, science systems and mission services. The Starlab Space Stations segment consists of a commercial space station. The company was founded by Dylan Taylor and Matthew Kuta on August 15, 2019 and is headquartered in Denver, CO.

Voyager Technologies Inc. - Ordinary Shares - Class A

Voyager Technologies Inc

Voyager Technologies is trending following its recent Q4 earnings, which reported record net sales and a substantial backlog driven by its defense segment, alongside a positive 2026 outlook. The community is actively engaged in discussions around this strong performance and the transformative potential of its Starlab commercial space station as it anticipates crucial NASA contract developments.

Casey's General Stores, Inc. engages in the provision of management and operation of convenience stores and gasoline stations. It provides self-service gasoline, a wide selection of grocery items, and an array of freshly prepared food items. The firm offers food, beverages, tobacco products, health and beauty aids, automotive products, and other non-food items. The company was founded by Donald F. Lamberti in 1968 and is headquartered in Ankeny, IA.

Casey`s General Stores, Inc.

Casey's General Stores, Inc.

Casey's General Stores is trending as its recent earnings reports, which often highlighted strong EPS performance and consistent inside sales, spark debate about its valuation amid occasional revenue misses and slowing same-store growth in key categories. The community actively discusses its unique model, notable pizza sales, and ongoing expansion within the convenience store sector.

Terrestrial Energy, Inc. is an advanced nuclear technology company focused on next-generation nuclear energy systems. The company is developing the Integral Molten Salt Reactor (IMSR), an innovative type of Generation IV molten salt reactor designed to produce reliable, low-carbon heat and electricity at competitive costs. The company is headquartered in Charlotte, NC.

Terrestrial Energy Inc.

Terrestrial Energy (IMSR) is drawing significant attention following its recent U.S. Department of Energy agreement for Project TEFLA, a crucial step in integral molten salt reactor fuel production, which the community sees as a catalyst for its long-term potential in powering AI data centers and positions it as an undervalued player in the advanced nuclear sector.

Hewlett Packard Enterprise Co. is a global edge-to-cloud company, which engages in the provision of information technology, technology and enterprise products, solutions, and services. It operates through the following segments: Server, Hybrid Cloud, Intelligent Edge, Financial Services, and Corporate Investments and Other. The Server segment consists of general-purpose servers for multi-workload computing and workload-optimized servers to deliver the performance and value for demanding applications, and integrated systems comprised of software and hardware designed to address high-performance computing and supercomputing, artificial intelligence, data analytics, and transaction processing workloads for government and commercial customers globally. The Hybrid Cloud segment is involved in a variety of cloud-native and hybrid solutions across storage, private cloud, and the infrastructure software-as-a-service space. The Intelligent Edge segment offers wired and wireless local area networks, campus, branch, and data center switching, software-defined wide-area-networks, private and public cellular network software, network security, and associated services that enable secure connectivity for businesses of any size. The Financial Services segment provides investment solutions, such as leasing, financing, IT consumption, utility programs, and asset management services for customers that facilitate technology deployment models and the acquisition of complete IT solutions, including hardware, software, and services from Hewlett Packard Enterprise and others. The Corporate Investments and Other segment includes the Advisory and Professional Services business, which primarily offers consultative-led services, HPE and partner technology expertise and advice, implementation services, as well as complex solution engagement capabilities, the Communications and Media Solutions business, which primarily offers software and related services to the telecommunications industry, and Hewlett Packard Labs, which is responsible for research and development. The company was founded by William R. Hewlett and David Packard on July 2, 1939 and is headquartered in Spring, TX.

Hewlett Packard Enterprise Co

Hewlett Packard Enterprise is trending following strong Q1 earnings that beat EPS estimates and demonstrated significant growth in its networking segment, fueled by robust AI demand and the strategic integration of Juniper Networks. The community is actively discussing HPE's positioning as an undervalued full-stack AI infrastructure player, poised to challenge competitors in both server and networking solutions.

AN2 Therapeutics, Inc. operates as a global health biopharmaceutical company. The firm focuses on modern biomedical and drug development to provide transformational medicines for patients suffering from infectious diseases. The company was founded by Eric Easom, George Harrison Talbot, Joseph S. Zakrzewski and Michael R.K. Alley and is headquartered in Menlo Park, CA.

AN2 Therapeutics Inc

AN2 Therapeutics is experiencing a massive price and volume surge as a short squeeze narrative takes hold, fueled by discussions around its recent private placement financing and updates to its lead candidate's Phase 3 trial status. Community sentiment is polarized between expectations of significant further gains and warnings of a pump-and-dump, reflecting the stock's historical volatility.

ProShares Trust - ProShares UltraShort Bloomberg Crude Oil -2x Shares

ProShares UltraShort Bloomberg Crude Oil

ProShares UltraShort Bloomberg Crude Oil (SCO) is trending as traders debate its tracking performance amidst extreme volatility in crude oil prices driven by geopolitical tensions. Many in the community are anticipating a significant pullback in oil from perceived overbought levels, viewing SCO as an opportunity to capitalize on an eventual decline.

KraneShares Trust - KraneShares CSI China Internet ETF

KraneShares CSI China Internet ETF

KWEB is trending as investors eye a significant rebound in Chinese internet stocks, fueled by expectations of progress in US-China trade relations and China's strategic pivot towards high-tech industries and domestic stimulus. Community sentiment highlights deeply oversold technicals and compelling valuations, with notable options flow indicating strong bullish conviction.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wednesday, 13 August 2025 08:30 AMTopic:&nbsp;<h4>Company Update</h4>&nbsp;TAMPA, FLORIDA / <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.accessnewswire.com/">ACCESS Newswire</a> / August 13, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics Health" or the "Company"), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced the launch of its Ripple Labs-powered XRP Implementation Program, giving independent pharmacies access to blockchain-based payments in the prescription drug space for the first time. The program enables pharmacies to pay for products and move funds instantly, more cost-effectively, and with full transparency-eliminating delays, high fees, and reliance on traditional banking and credit card networks. Wellgistics Health is among the first healthcare companies to implement an XRP-based payment solution at scale.The program operates in partnership with RxERP, a serialized pharmaceutical eCommerce and ERP (Enterprise Resource Planning) system that manages onboarding, transactions, and reporting for participating pharmacies. With Wellgistics already serving more than 6,500 independent pharmacies and over 200 manufacturers nationwide, the Company is well-positioned to accelerate adoption rapidly and at scale.Pharmacies can now enroll in the beta program at:<a target="_blank" rel="noopener noreferrer nofollow" href="https://pr.report/d8zp">https://wellgisticshealth.com/xrp-in-healthcare/</a>How Pharmacies Benefit from Using XRP<ul><li>Instant Settlement - Payments settle in seconds, not days</li><li>Lower Fees - Avoid credit card and bank transaction costs</li><li>24/7 Availability - No banking delays, even on weekends and holidays</li><li>Improved Cash Flow - Faster access to working capital and inventory restock</li><li>Real-Time Tracking - View and confirm payments instantly</li><li>No Intermediaries - Direct transactions between pharmacy and distributor</li></ul>"We've been impressed with the response so far," said Brian Norton, CEO of Wellgistics Health. "Independent pharmacy owners are far more forward-thinking than many realize. They see the power of blockchain and understand how transformative this will be as it scales across the industry. Our mission is to give pharmacies greater control, speed, and transparency in their financial operations."Technical Innovation and Blockchain IntegrationThe XRP Payment Program harnesses the speed, scalability, and low-cost infrastructure of the XRP Ledger to meet the unique demands of the pharmaceutical supply chain. Integrated with RxERP, the platform delivers real-time, encrypted, and fully compliant payment processing tailored for independent pharmacies, wholesalers and in the near future, manufacturers.Pharmacies and investors can learn more by downloading the Wellgistics Health XRP E-Book:<a target="_blank" rel="noopener noreferrer nofollow" href="https://pr.report/d8zq">https://wellgisticshealth.com/xrp-in-healthcare/</a>Regulatory Compliance and SecurityThe XRP Payment Program has been developed to meet or exceed healthcare and financial regulatory standards, including HIPAA and anti-money laundering (AML) requirements. The system provides secure, traceable transactions while safeguarding sensitive data and maintaining privacy at every stage.Next Phase: Manufacturer Onboarding and Direct-to-Patient (DTP) ProgramsFollowing the pharmacy rollout, Wellgistics Health will begin onboarding pharmaceutical manufacturers to the XRP platform-expanding capabilities for direct, on-chain transactions. The Company also plans to launch manufacturer-powered Direct-to-Patient (DTP) programs, allowing manufacturers to ship medications directly to patients' homes in collaboration with their community pharmacy and prescribing physicians to ensure clinical continuity and compliance."Pharmacies deserve a payment system as fast and responsive as the care they provide," said Tony Madsen, COO of Wellgistics Health. "While this first phase focuses on helping pharmacies pay for products more efficiently, it's just the start. Our vision is to make every aspect of pharmacy payments faster, clearer, and completely frictionless."About Wellgistics HealthWellgistics Health (NASDAQ: WGRX) delivers medications from manufacturer to patient-faster, smarter, and more affordably. Its integrated platform connects 6,500+ independent pharmacies and 200+ U.S. manufacturers, providing wholesale distribution, digital prescription routing, and AI-powered hub services such as eligibility, adherence, onboarding, prior authorization, and cash-pay fulfillment. As a PBM-agnostic alternative, Wellgistics Health offers compliant, end-to-end solutions that restore access, transparency, and trust in U.S. healthcare.About RxERPRxERP is the only serialized pharmaceutical ERP system designed specifically for independent pharmacies, wholesalers, and manufacturers. It delivers real-time financial, operational, and compliance tools-integrating blockchain, AI, and serialized inventory management to streamline operations and modernize the supply chain. RxERP is the platform partner managing the XRP Implementation Program with Wellgistics Health.Forward-Looking StatementsThis press release may contain forward-looking statements regarding Wellgistics Health's plans, strategies, future operations, and expected performance. These statements are based on current expectations and involve risks and uncertainties that may cause actual results to differ materially. Factors that could affect these results include, but are not limited to, market conditions and risks detailed in filings with the SEC. Investors are cautioned not to place undue reliance on forward-looking statements. Additional information is available at www.sec.gov.Media Contact: <a target="_blank" rel="noopener noreferrer nofollow" href="mailto:media@wellgisticshealth.com">media@wellgisticshealth.com</a> Investor Relations: <a target="_blank" rel="noopener noreferrer nofollow" href="mailto:investors@wellgisticshealth.com">investors@wellgisticshealth.com</a>Investor Relations Contact: Skyline Corporate Communications Group, LLC Scott Powell, President 1177 Avenue of the Americas, 5th Floor New York, NY 10036 Office: (646) 893-5835 Email: <a target="_blank" rel="noopener noreferrer nofollow" href="mailto:info@skylineccg.com">info@skylineccg.com</a>SOURCE: Wellgistics Health, Inc.Note: This article has been published automatically by sourcing from Access Newswire. The Stocktwits editorial team did not edit this article.

Wellgistics Health (NASDAQ: WGRX) Launches XRP Payment Program for Independent Pharmacies

https://www.accessnewswire.com/newsroom/en/blockchain-and-cryptocurrency/wellgistics-health-nasdaq-wgrx-launches-xrp-payment-program-for-indep-1060334

Others

Wellgistics Health, Inc., a holding company focused on pharmaceuticals and healthcare services, has drawn significant retail investor attention since going public on Feb. 21.&nbsp;Despite closing below its $4.50 IPO price on day one, the Tampa, Florida-based company has seen its Stocktwits follower count surge by over 960%, with a six-fold increase in the last week alone, the highest for any healthcare firm on Stocktwits during this period.Message volume on the platform about the stock has also skyrocketed by 10,800% since its market debut.So, what's fueling the buzz? Let's break down the key developments since the IPO.Strategic Partnerships &amp; Product ExpansionLate last month, Wellgistics announced an agreement with Tollo Health to market its proprietary medical food products, addressing the side effects of GLP-1 treatments and long-term COVID-19.&nbsp;Tollo's flagship product, Galectovid, is designed to manage dietary Galectin-1 and 3-associated viral infections, muscle loss, and gut discomfort linked to GLP-1 drug use.Earlier this month, Wellgistics partnered with Protega Pharmaceuticals, the maker of Roxybond, an FDA-approved abuse-deterrent opioid pain medication.&nbsp;The collaboration aims to enhance pharmacist education on abuse-deterrent pain management and expand access to Roxybond, particularly in underserved rural areas, via Wellgistics' independent pharmacy clients.Leadership Change &amp; Compliance MilestoneEarlier this month, Wellgistics appointed Brian Norton as its new CEO, replacing Tim Canning. Under his leadership, the company plans to improve operational efficiency, optimize sales, advance its technology roadmap, and explore acquisition opportunities.Retail investors on Stocktwits took note of Norton's Fox Business&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.foxbusiness.com/video/6370288081112">interview</a> on Thursday, in which he said U.S. pharmacy benefit managers (PBMs) had failed to lower drug prices and instead led to rising costs.&nbsp;He said Wellgistics aims to address this by providing affordable medications and ensuring safe opioid administration.&nbsp;<stembedurl>https://stocktwits.com/Paraboljoker/message/608773239</stembedurl>Norton also advocated for scrutinizing PBMs, supporting independent pharmacies, and ensuring pricing transparency to empower patients.Since its Nasdaq debut in February, Wellgistics stock has climbed more than 8%, signaling strong investor confidence in the newcomer.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

Why Retail Traders Are Rushing Into Small-Cap Wellgistics Health Weeks After Its Nasdaq Debut

The CEO has said the company aims to address the failures of pharmacy benefit managers by providing affordable medications and ensuring safe opioid administration.

Equity

The CEO has said the company aims to address the failures of pharmacy benefit managers by providing affordable medications and ensuring safe opioid administration.


Wellgistics Health, Inc. operates as a holding company centered around pharmaceuticals and healthcare services. Its business portfolio consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services. The company was founded by Ajjarapu Surendra on September 6, 2022 and is headquartered in Tampa, FL.

WGRX
Wellgistics Health Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest WGRX News

WGRXWellgistics Health Inc.